Clear all

Refine your search

Content type
Tags
Firm name
Author
Jurisdiction
Language

674 results found

Article
Ask Lexy

Fenwick & West LLP | USA | 18 Dec 2018

Patent Owners Win as Federal Circuit Reins in Gilead and AbbVie Double Patenting Rulings

In a pair of patent owner victories, the U.S. Court of Appeals for the Federal Circuit issued decisions limiting the applicability of obviousness-type…
Article
Ask Lexy

AA Thornton | Global | 3 Oct 2018

WIPO Magazine has announced the launch of a new tool linking patents and drugs: Pat-INFORMED

The World Intellectual Property Organization (WIPO) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)…
Article
Ask Lexy

Seyfarth Shaw LLP | USA | 15 Aug 2018

Federal Court Leaves Opportunity For A “Compelling” Exhaustion Argument

The U.S. District Court for the District of New Jersey recently issued a ruling with respect to Defendants’ “compelling” exhaustion…
Commentary
Ask Lexy

Grau & Angulo | Spain | 7 May 2018

Barcelona patent court revokes preliminary injunction granted ex parte in NuvaRing case

Barcelona Commercial Court Number 5 recently revoked a preliminary injunction which had been granted ex parte at the request of Merck Sharp & Dohme BV (MSD) for alleged patent infringement. This case is notable, as the defendants' product – which is the first competitor of MSD's contraceptive vaginal ring, NuvaRing – is manufactured in Spain and sold in several European countries where other......
Article
Ask Lexy

Morrison & Foerster LLP | USA | 7 May 2018

Hatch-Waxman and BPCIA Developments for April 2018

This month, we highlight several significant cases, including the Supreme Court’s decisions in Oil States and SAS, and the Federal Circuit’s decisions…
Article
Ask Lexy

Banner Witcoff | USA | 2 May 2018

Is Functional Similarity Between Compounds Sufficient to Create a Prima Facie Case of Obviousness?

Anacor Pharmaceuticals, the dissatisfied patent owner in an inter partes review (IPR), and the U.S. Patent and Trademark Office (USPTO) as intervenor…
Article
Ask Lexy

Rothwell, Figg, Ernst & Manbeck, PC | USA | 3 Apr 2018

Global Approvals for Insulin Glargine Promise a More Affordable, Long-Acting Treatment for Diabetes

Last week, Mylan N.V. and Biocon Ltd. announced that their jointly-developed insulin glargine biosimilar, Semglee™, received marketing approval from…
Article
Ask Lexy

Reed Smith LLP | USA | 19 Mar 2018

Legal Black Holes Proliferate After Stephen Hawking’s Death - Massachusetts Allows Somewhat Limited Innovator Liability

Stephen Hawking may have been the smartest guy in the world, even though he believed that “People who boast about their I.Q. are losers.” Hawking is…
Article
Ask Lexy

Banner Witcoff | USA | 22 Feb 2018

Confidentiality Agreements Get Teeth

Do you consider Non-Disclosure Agreements (NDAs) and Material Transfer Agreements (MTAs) mere hoops to jump through before you can get what you really…
Article
Ask Lexy

Knobbe Martens | USA | 9 Feb 2018

Merck Sharp & Dohme Corp. v. Amneal Pharmaceuticals Llc

Proceeding to trial despite a party’s violation of a discovery order was not an abuse of discretion where the District Court took adequate steps to…
Previous page 1 2 3 ...